Skip to main content

Table 1 Characteristics of the study population and association analysis with pneumococcal colonization

From: Pneumococcal colonization in older adults

  

Total n = 417

Negative n = 376

Positive n = 41

Odds ratio (95 % CI)

p-value

Adjusted odds ratio (95 % CI)

p-value

Age

<75 years

246 (58.99)

218 (57.98)

28 (68.29)

(reference)

 

(reference)

 

≥75 years

171 (41.01)

158 (42.02)

13 (31.71)

0.641 (0.322–1.276)

0.205

0.685 (0.332–1.414)

0.306

Mean age (sd)

 

73.97 (6.66)

74.13 (6.64)

72.49 (6.76)

0.961 (0.911–1.013)

0.135

0.969 (0.917–1.025)

0.277

Sex

Male

115 (27.58)

106 (28.19)

9 (21.95)

(reference)

 

(reference)

 

Female

302 (72.42)

270 (71.81)

32 (78.05)

1.396 (0.644–3.023)

0.398

1.208 (0.549–2.658)

0.638

Ethnicity

Caucasian

403 (96.64)

366 (97.34)

37 (90.24)

(reference)

 

(reference)

 

Non-Caucasian

10 (2.4)

8 (2.13)

2 (4.88)

2.473 (0.506–12.078)

0.263

1.862 (0.37–9.384)

0.451

NA

4 (0.96)

2 (0.53)

2 (4.88)

    

Mean number of cohabitants (sd)

 

0.22 (0.55)

0.23 (0.56)

0.11 (0.39)

0.563 (0.228–1.393)

0.214

0.441 (0.152–1.275)

0.131

Children cohabitants

No

401 (96.16)

361 (96.01)

40 (97.56)

    

Yes

2 (0.48)

2 (0.53)

0 (0)

NE

NE

NE

NE

NA

14 (3.36)

13 (3.46)

1 (2.44)

    

Nephew

No

195 (46.76)

179 (47.61)

16 (39.02)

(reference)

 

(reference)

 

Yes

89 (21.34)

82 (21.81)

7 (17.07)

0.955 (0.378–2.41)

0.922

0.856 (0.325–2.253)

0.753

NA

133 (31.89)

115 (30.59)

18 (43.9)

    

Marital status

Married/Cohabiting

223 (53.48)

200 (53.19)

23 (56.1)

(reference)

 

(reference)

 

Single

57 (13.67)

52 (13.83)

5 (12.2)

0.836 (0.303–2.305)

0.729

0.652 (0.214–1.982)

0.451

Separated

53 (12.71)

47 (12.5)

6 (14.63)

1.11 (0.428–2.879)

0.83

1.129 (0.429–2.971)

0.806

Widowed

83 (19.9)

76 (20.21)

7 (17.07)

0.801 (0.33–1.943)

0.623

0.994 (0.395–2.503)

0.99

NA

1 (0.24)

1 (0.27)

0 (0)

    

Smoker

No

367 (88.01)

331 (88.03)

36 (87.8)

(reference)

 

(reference)

 

Yes

49 (11.75)

44 (11.7)

5 (12.2)

1.045 (0.389–2.803)

0.931

0.78 (0.261–2.331)

0.657

NA

1 (0.24)

1 (0.27)

0 (0)

    

Respiratory allergy

No

291 (69.78)

265 (70.48)

26 (63.41)

(reference)

 

(reference)

 

Yes

126 (30.22)

111 (29.52)

15 (36.59)

1.377 (0.703–2.7)

0.351

1.208 (0.602–2.424)

0.596

Co-morbidities

No

137 (32.85)

117 (31.12)

20 (48.78)

(reference)

 

(reference)

 

Yes

278 (66.67)

258 (68.62)

20 (48.78)

0.453 (0.235–0.875)

0.018

0.503 (0.255–0.992)

0.047

NA

2 (0.48)

1 (0.27)

1 (2.44)

    

Group of co-morbidities

Respiratory

86 (20.62)

79 (21.01)

7 (17.07)

0.518 (0.209–1.284)

0.156

0.613 (0.236–1.59)

0.314

Cardiac

120 (28.78)

114 (30.32)

6 (14.63)

0.308 (0.119–0.795)

0.015

0.341 (0.13–0.894)

0.029

Metabolic

23 (5.52)

20 (5.32)

3 (7.32)

0.877 (0.238–3.229)

0.844

0.945 (0.255–3.51)

0.933

Tumours

10 (2.4)

10 (2.66)

0 (0)

NE

NE

NE

NE

Thyroid

23 (5.52)

20 (5.32)

3 (7.32)

0.877 (0.238–3.229)

0.844

0.848 (0.23–3.13)

0.805

Other

16 (3.84)

15 (3.99)

1 (2.44)

0.39 (0.049–3.119)

0.375

0.448 (0.055–3.639)

0.453

None

137 (32.85)

117 (31.12)

20 (48.78)

(reference)

 

(reference)

 

NA

2 (0.48)

1 (0.27)

1 (2.44)

    

Pneumococcal vaccination

No

389 (93.29)

349 (92.82)

40 (97.56)

(reference)

 

(reference)

 

Yes

28 (6.71)

27 (7.18)

1 (2.44)

0.323 (0.043–2.44)

0.273

0.389 (0.051–2.969)

0.362

Type of vaccination

PCV13

10 (2.4)

10 (2.66)

0 (0)

    

PPV23

17 (4.08)

16 (4.26)

1 (2.44)

NE

NE

NE

NE

NA

390 (93.53)

350 (93.09)

40 (97.56)

    

Influenza vaccination in the previous season

No

215 (51.56)

191 (50.8)

24 (58.54)

(reference)

 

(reference)

 

Yes

202 (48.44)

185 (49.2)

17 (41.46)

0.731 (0.38–1.406)

0.348

0.84 (0.419–1.682)

0.623

Mean number of respiratory infections in the previous 6 months (sd)

0.9 (1.87)

0.89 (1.92)

0.97 (1.32)

1.022 (0.863–1.211)

0.798

0.998 (0.827–1.203)

0.981

Mean number of upper respiratory tract in the previous 6 months (sd)

0.61 (1.64)

0.6 (1.67)

0.74 (1.29)

1.046 (0.874–1.251)

0.625

1.005 (0.817–1.235)

0.966

Mean number of lower respiratory tract infections in the previous 6 months (sd)

0.28 (0.68)

0.29 (0.69)

0.22 (0.48)

0.823 (0.45–1.504)

0.526

0.899 (0.49–1.646)

0.729

Hospitalizations in the last 3 months

No

404 (96.88)

363 (96.54)

41 (100)

    

Yes

13 (3.12)

13 (3.46)

0 (0)

NE

NE

NE

NE

Emergency Room visit in the last 3 months

No

388 (93.05)

352 (93.62)

36 (87.8)

(reference)

 

(reference)

 

Yes

24 (5.76)

21 (5.59)

3 (7.32)

1.397 (0.397–4.912)

0.602

1.651 (0.46–5.928)

0.442

NA

5 (1.2)

3 (0.8)

2 (4.88)

    

Treatments with antibiotic in the last month

No

368 (88.25)

328 (87.23)

40 (97.56)

(reference)

 

(reference)

 

Yes

49 (11.75)

48 (12.77)

1 (2.44)

0.171 (0.023–1.271)

0.084

0.155 (0.021–1.158)

0.069

Pneumococcal infections in the last month

No

363 (87.05)

326 (86.7)

37 (90.24)

(reference)

 

(reference)

 

Yes

54 (12.95)

50 (13.3)

4 (9.76)

0.705 (0.241–2.063)

0.523

0.606 (0.204–1.802)

0.368

  1. Odds ratios, with pertinent 95 % CIs and p-values, are obtained by logistic regression. Adjustment is made for age and the presence of co-morbidity, which are potentially confounding factors
  2. 95 % CI 95 % confidence interval, NA not available, NE not executable OR odds ratio, PCV13 13-valent pneumococcal vaccine, PPV23 23-valent polysaccharide pneumococcal vaccine, SD standard deviation
  3. Bold data indicate significant differences